Stent placement compared with balloon angioplasty for small coronary arteries - In-hospital and 6-month clinical and angiographic results

Citation
R. Koning et al., Stent placement compared with balloon angioplasty for small coronary arteries - In-hospital and 6-month clinical and angiographic results, CIRCULATION, 104(14), 2001, pp. 1604-1608
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
104
Issue
14
Year of publication
2001
Pages
1604 - 1608
Database
ISI
SICI code
0009-7322(20011002)104:14<1604:SPCWBA>2.0.ZU;2-X
Abstract
Background-Stenting has been demonstrated to be superior to balloon angiopl asty in de novo focal lesions located in large native vessels. However, in small vessels, the benefit of stenting remains questionable. Methods and Results-A total of 381 symptomatic patients with de novo focal lesion located on a small coronary segment vessel (<3 mm) were randomly ass igned to either stent implantation (192 patients; 197 lesions) or standard balloon angioplasty (189 patients; 198 lesions). The primary end point was the angiographic restenosis rate at 6 months, as determined by quantitative coronary angiography. On intention-to-treat analysis, angiographic success rate and major adverse cardiac events were comparable: 97.9% and 4.6% vers us 93.9% and 5.8% in the stent group and the balloon group, respectively. A fter the procedure, a larger acute gain was achieved with stent placement ( 1.35 +/-0.45 versus 0.94 +/-0.47 mm, P=0.0001), resulting in a larger minim al lumen diameter (2.06 +/-0.42 versus 1.70 +/-0.46 mm, P=0.0001). At follo w-up (obtained in 91% of patients), angiographic restenosis rate was 21% in the stent group versus 47% in the balloon group (P=0.0001), a risk reducti on of 55%. Repeat target lesion revascularization was less frequent in the stent group (13% versus 25%, P=0.0006). Conclusions-Elective stent placement in small coronary arteries with focal de novo lesions is safe and associated with a marked reduction in restenosi s rate and subsequent target lesion revascularization rate at 6 months.